Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
K2bio is a private Houston-based life science services company focused on helping early-stage biopharma companies advance programs from discovery through IND-enabling work. The company operates as an integrated preclinical CRO and lab-incubator provider, offering in vitro research, in vivo pharmacology, analytical development, histology, regulatory support, and flexible turnkey lab space. Its infrastructure includes BSL-2 laboratory space, a CLIA lab, and an AAALAC-accredited, OLAW-compliant contract vivarium positioned near the Texas Medical Center. K2bio appears to serve biotech and pharmaceutical clients rather than developing a proprietary therapeutic pipeline of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on K2 Biotechnologies.